Iambic Therapeutics
OrganizationBiotech
Minutes holds 4 developments and 4 deals naming Iambic Therapeutics, recorded from October 2023.
Funding
- 3
- $250M
- Funding round
- 27
- IPO on record
Funding rounds
| Date | Round | Amount | Post-money | Led by | Returning |
|---|---|---|---|---|---|
| 10 November 2025 | Funding round | at least $100M | — | — | 6 of 16 |
| 18 June 2024 | Series B extension | $50M | — | Mubadala Capital, Exor Ventures | 4 of 8 |
| 3 October 2023 | Series B | $100M | — | Ascenta Capital, Abingworth | 0 of 13 |
Investors
| Investor | Kind | First round | Rounds joined | Led |
|---|---|---|---|---|
| Abingworth | Organization | 3 October 2023 | 3 | 1 |
| Mubadala Capital | Asset manager | 18 June 2024 | 1 | 1 |
| Exor Ventures | Organization | 18 June 2024 | 1 | 1 |
| Ascenta Capital | Organization | 3 October 2023 | 1 | 1 |
| Illumina Ventures | Organization | 3 October 2023 | 3 | 0 |
| Catalio Capital Management | Venture capital | 3 October 2023 | 2 | 0 |
| Qatar Investment Authority | Sovereign wealth fund | 18 June 2024 | 2 | 0 |
| Sequoia Capital | Venture capital | 3 October 2023 | 2 | 0 |
| Tao Capital Partners | Organization | 18 June 2024 | 2 | 0 |
| Alexandria Venture Investments | Organization | 10 November 2025 | 1 | 0 |
| Alumni Ventures | Venture capital | 10 November 2025 | 1 | 0 |
| ARK Invest | Asset manager | 10 November 2025 | 1 | 0 |
| Ascenta | Organization | 10 November 2025 | 1 | 0 |
| Everbright Biofund | Organization | 10 November 2025 | 1 | 0 |
| Freeflow Ventures | Organization | 10 November 2025 | 1 | 0 |
| Pegasus Tech Ventures | Organization | 10 November 2025 | 1 | 0 |
| Regeneron Ventures | Organization | 10 November 2025 | 1 | 0 |
| Terra Magnum Capital Partners | Organization | 10 November 2025 | 1 | 0 |
| Wilson Sonsini Goodrich & Rosati | Organization | 10 November 2025 | 1 | 0 |
| Nexus Venture Partners | Venture capital | 3 October 2023 | 2 | 0 |
| Coatue | Asset manager | 3 October 2023 | 2 | 0 |
| NVIDIA | Company | 3 October 2023 | 1 | 0 |
| Gradiant Corporation | Organization | 3 October 2023 | 1 | 0 |
| Shanda | Organization | 3 October 2023 | 1 | 0 |
| FreeFlow | Organization | 3 October 2023 | 1 | 0 |
| OrbiMed | Organization | 3 October 2023 | 1 | 0 |
| Tao Capital | Organization | 3 October 2023 | 1 | 0 |
Investors named in rounds Minutes has recorded. Undisclosed participants are not listed.
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Iambic TherapeuticsBiotech | IPO | $150M | Not recorded | 14 Oct | Closed |
| Iambic TherapeuticsBiotech | Funding | At least $100M | Investors Abingworth, Alexandria Venture Investments +14 | 10 Nov 2025 | Closed |
| Iambic TherapeuticsBiotech | FundingSeries B extension | $50M | Led by Mubadala Capital, Exor VenturesWith Qatar Investment Authority, Abingworth +4 | 18 Jun 2024 | Closed |
| Iambic TherapeuticsBiotech | FundingSeries B | $100M | Led by Ascenta Capital, AbingworthWith NVIDIA, Illumina Ventures +9 | 3 Oct 2023 | Closed |
- FundingSeries B extension, led by Mubadala Capital +7Biotech · 18 Jun 2024 · Closed